FREE WEBINAR – Alpha-1 Antitrypsin Deficiency (AATD) in COPD

May 16, 2019 – Join us to discuss the burden of Alpha-1 Antitrypsin Deficiency in COPD and understand the implications for your patients.



Individuals with AATD will have a higher predisposition to developing emphysema and COPD. Therefore, it is important to understand its burden, the treatments available and how they can help improve your patients’ quality of life. 

Webinar: Alpha-1 Antitrypsin Deficiency in COPD


  • To understand AATD and the consequences for an individual with COPD
  • To identify the target clientele who should be tested for AATD
  • To understand the diagnostic process
  • To understand the treatment, including augmentation therapy, as well as long-term adherence and lifestyle improvements to live better with AATD 


Miriam Barrecheguren, MD, PhD, is a pneumologist who currently works at Vall d’Hebron University Hospital in Barcelona. Her main areas of interest include COPD, AATD and mechanical ventilation. After earning her Ph.D. in 2016, on the diagnosis and management of COPD and AATD in Primary Care, she fulfilled a research fellow at McGill University and was then granted a Rio Hortega grant to continue her work in Barcelona. She is the Early Career representative for the European Respiratory Society (ERS) in the European Alpha-1 research collaboration (EARCO). 

Sébastien Gagnon, MD, is a respirologist who has trained at the Institut Universitaire de Cardiologie et Pneumologie de Québec (IUCPQ), in Quebec City. He is currently doing a fellowship at McGill University under the direction of Dr. Jean Bourbeau. His interests are COPD treatment, new approaches for treatment of breathlessness, as well as Pulmonary Rehabilitation.  


Dr. Miriam Barrecheguren – Friday June 7, 2019 @ 12 PM EST 

Register here for Miriam Barrecheguren                        


Dr. Sébastien Gagnon – Monday June 10, 2019 @ 3 PM EST

Register here for Dr. Sébastien Gagnon

This free webinar is part of eXpand – a new online training platform for professionals treating patients with COPD, Asthma, Pulmonary Fibrosis and other chronic pulmonary disease. Improve your skills and knowledge to support your patients in the long-term integration of self-management and a healthy lifestyle. 

To learn more about eXpand courses, visit: 

Brought to you by RESPIPLUS and made possible thanks to an educational grant by Grifols.



Back to list